A retrospective study to evaluate safety and efficacy of different disease modifying treatments who failed Alemtuzumab therapy
Latest Information Update: 23 Jan 2020
At a glance
- Drugs Glatiramer acetate (Primary) ; Ocrelizumab (Primary) ; Teriflunomide (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- 23 Jan 2020 New trial record